- Home
- COYA
as 11-03-2025 4:00pm EST
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Upcoming Earnings Alert:
Get ready for potential market movements as Coya Therapeutics Inc. COYA prepares to release earnings report on 06 Nov 2025.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 107.0M | IPO Year: | 2022 |
| Target Price: | $16.20 | AVG Volume (30 days): | 299.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.65 - $8.29 | Next Earning Date: | 11-06-2025 |
| Revenue: | $423,452 | Revenue Growth: | -95.57% |
| Revenue Growth (this year): | 40.8% | Revenue Growth (next year): | -86.75% |
Latest Coya Therapeutics Inc. News
COYA Breaking Stock News: Dive into COYA Ticker-Specific Updates for Smart Investing
Insider Monkey
7 days ago
Here’s Greenlight Capital’s Update on Coya Therapeutics (COYA)
Business Wire
7 days ago
Coya Therapeutics Announces Closing of $23.0 Million Upsized Public Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
MT Newswires
11 days ago
Investors Digest September Inflation Report, Lifting US Equity Futures Pre-Bell
MT Newswires
11 days ago
Coya Therapeutics Prices $20 Million Public Offering of Common Stock; Shares Fall Pre-Bell
MT Newswires
11 days ago
Top Premarket Decliners
Business Wire
11 days ago
Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock
MT Newswires
11 days ago
Coya Therapeutics Plans Public Stock Offering
Simply Wall St.
11 days ago
Coya Therapeutics (COYA) Valuation in Focus After Follow-On Equity Offering Announced
Compare COYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COYA Coya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.